|
Group
| | | |
---|
|
Controls (N) N = 11
|
AD/HD (A) N = 10
|
AD/HD+ODD/CD (AO) N = 11
|
ODD/CD (O) N = 8
|
ANCOVA (covariate "age")
| |
Measure
|
Mean (SD)
|
Mean (SD)
|
Mean (SD)
|
Mean (SD)
|
F
(3,35)
|
p
|
Planned contrasts
|
Go-Trial ROIa mean amplitude (μV)
|
-3.20 (1.68)
|
-2.64 (2.10)
|
-2.25 (2.36)
|
-1.98 (2.18)
|
.80
|
.50
| |
Stop-Trial ROIa mean amplitude (μV)
|
-5.36 (1.69)
|
-1.94 (4.00)
|
-2.89 (2.21)
|
-1.90 (4.20)
|
3.15
|
.04*
|
N<A*, AO*, O*/A = AO = O
|
Stop-N200 ROIa mean amplitude (μV)
|
-2.16 (1.60)
|
.69 (3.43)
|
-.63 (1.76)
|
.07 (2.02)
|
2.54
|
.07+
|
N<A*, AO+, O*/A = AO = O
|
- * one-tailed, p < .05
- + one-tailed, p < .10
- a Region of interest, mean of electrodes F4 and F8 at 420–500 ms post Go-signal onset